Intervention not reported
Overall survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
185 participants
Low
Intervention not reported
Recurrence‐free survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
185 participants
Low
Intervention not reported
Number and type of adverse events · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Duration of hospital stay · hospitalised people with early HCC treated with PEI, PAI, or surgery.
1 finding from 1 review
no estimate extracted
125 participants
Very low
Intervention not reported
Quality of life · hospitalised people with early HCC treated with PEI, PAI, or surgery.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success rate · people (>14 years) with kidney stones
ESWL may leads to lower treatment success rate at 3 months MCID: 5% absolute difference compared with PCNL (low certainty).
1 finding from 1 review
Retreatment · people (>14 years) with kidney stones
ESWL probably leads to higher retreatment rate MCID: 3% absolute difference compared with RIRS (moderate certainty).
1 finding from 1 review
Auxiliary procedures rate MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL may leads to higher auxiliary procedures rate MCID: 3% absolute difference compared with RIRS (low certainty).
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · people (>14 years) with kidney stones
1 finding from 1 review
Quality of life Assumed MCID: NA · people (>14 years) with kidney stones
1 finding from 1 review
Complications MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL probably leads to lower complications MCID: 3% absolute difference compared with PCNL (moderate certainty).
1 finding from 1 review
Retreatment · people (>14 years) with kidney stones
ESWL may leads to higher retreatment rate MCID: 3% absolute difference compared with PCNL (low certainty).
1 finding from 1 review
Auxiliary procedures rate MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL probably leads to higher auxiliary procedures rate MCID: 3% absolute difference compared with PCNL (moderate certainty).
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · people (>14 years) with kidney stones
1 finding from 1 review
Treatment success rate · people (>14 years) with kidney stones
ESWL may leads to lower treatment success rate at 3 months MCID: 5% absolute difference compared with RIRS (low certainty).
1 finding from 1 review
Quality of life MCID varies by instrument. · people (>14 years) with kidney stones
1 finding from 1 review
Complications MCID: 3% absolute difference · people (>14 years) with kidney stones
It is very uncertain whether ESWL changes complications MCID: 3% absolute difference compared with RIRS (very low certainty).
1 finding from 1 review